145 related articles for article (PubMed ID: 34983678)
1. Eales' disease: epidemiology, diagnostic and therapeutic concepts.
Murillo López S; Medina Medina S; Murillo López F
Int J Retina Vitreous; 2022 Jan; 8(1):3. PubMed ID: 34983678
[TBL] [Abstract][Full Text] [Related]
2. Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease.
Kumar A; Sehra SV; Thirumalesh MB; Gogia V
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):685-90. PubMed ID: 22169980
[TBL] [Abstract][Full Text] [Related]
3. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
[TBL] [Abstract][Full Text] [Related]
4. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).
El-Asrar AM; Al-Kharashi SA
Br J Ophthalmol; 2002 Nov; 86(11):1248-51. PubMed ID: 12386081
[TBL] [Abstract][Full Text] [Related]
5. Further evidence of the association of latent Mycobacterium tuberculosis in Eales' disease.
Gupta P; Biswas J
Int Ophthalmol; 2021 Mar; 41(3):901-906. PubMed ID: 33200391
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Intravitreal Bevacizumab for Retinal Neovascularization in Eales' Disease Associated With Latent Mycobacterium Tuberculosis.
Gonzalez Martinez OG; Villegas VM; Oliver AL; Santos C
Cureus; 2023 Jun; 15(6):e41003. PubMed ID: 37503481
[TBL] [Abstract][Full Text] [Related]
7. Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales' disease.
Kharel Sitaula R; Iyer V; Noronha V; Dutta Majumder P; Biswas J
J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):4. PubMed ID: 28101723
[TBL] [Abstract][Full Text] [Related]
8. [Eales' disease].
Errera MH; Pratas A; Goldschmidt P; Sedira N; Sahel JA; Benesty J
J Fr Ophtalmol; 2016 May; 39(5):474-82. PubMed ID: 27185661
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of minimally invasive vitrectomy surgery in Eales' disease.
Khanduja S; Gupta S; Sinha S; Venkatesh P; Vohra R; Garg S
Nepal J Ophthalmol; 2013; 5(2):182-9. PubMed ID: 24172552
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes for vitrectomy in Eales' disease.
Shukla D; Kanungo S; Prasad NM; Kim R
Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
[TBL] [Abstract][Full Text] [Related]
11. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study.
Patwardhan SD; Azad R; Shah BM; Sharma Y
Retina; 2011 May; 31(5):866-70. PubMed ID: 21301382
[TBL] [Abstract][Full Text] [Related]
12. New classification system-based visual outcome in Eales' disease.
Saxena S; Kumar D
Indian J Ophthalmol; 2007; 55(4):267-9. PubMed ID: 17595474
[TBL] [Abstract][Full Text] [Related]
13. [Eales' disease--10 years experience with a rare disease].
Stoffelns BM; Kramann C; Schoepfer K
Klin Monbl Augenheilkd; 2009 Apr; 226(4):299-304. PubMed ID: 19384787
[TBL] [Abstract][Full Text] [Related]
14. Eales' Disease: When the Rare Sounds Frequent.
Lopes BO; Brízido MS; Reis AI; Miranda MM; Pina SM
Case Rep Ophthalmol Med; 2021; 2021():1056659. PubMed ID: 34422421
[TBL] [Abstract][Full Text] [Related]
15. Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.
Alfayyadh MA; Alabdulhadi HA; Almubarak MH
Cureus; 2021 Sep; 13(9):e18302. PubMed ID: 34722077
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features, Long-Term Outcomes, and Prognostic Factors of Eales' Disease in Korean Patients.
Lee SM; Jung JH; Lee J; Choi EY; Shin JY; Kim M
Ocul Immunol Inflamm; 2023 Mar; ():1-7. PubMed ID: 36897992
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab as an adjunct to vitrectomy in advanced Eales' disease.
Thakar M; Bamrolia NR; Raina UK; Ghosh B
J Ophthalmic Inflamm Infect; 2012 Jun; 2(2):105-8. PubMed ID: 22089976
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease.
Dehghan MH; Ahmadieh H; Soheilian M; Azarmina M; Mashayekhi A; Naghibozakerin J
Eur J Ophthalmol; 2005; 15(3):379-83. PubMed ID: 15945008
[TBL] [Abstract][Full Text] [Related]
19. Progression of Eales' disease post-partum and long-term follow-up: a case report.
Ivanescu R; Ivanescu C; Januschowski K; Ivanescu A
J Med Case Rep; 2018 Oct; 12(1):310. PubMed ID: 30326970
[TBL] [Abstract][Full Text] [Related]
20. Role of intravitreal bevacizumab in the management of Eales' disease.
Chanana B; Azad RV; Patwardhan S
Int Ophthalmol; 2010 Feb; 30(1):57-61. PubMed ID: 19165424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]